Skip to main content
Log in

Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals

  • Letter to the Editor
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Clark PM, Hales CN. How to measure plasma insulin. Diabetes Metab Rev. 1994;10(2):79–90.

    Article  PubMed  CAS  Google Scholar 

  2. Ido Y, Vindigni A, Chang K, et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science (New York, NY). 1997;277(5325):563–6.

    Article  CAS  Google Scholar 

  3. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia. 1992;35(2):121–8.

    Article  PubMed  CAS  Google Scholar 

  4. Irwin ML, Duggan C, Wang CY, et al. Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(1):47–53.

    Article  CAS  Google Scholar 

  5. Chen CH, Tsai ST, Chou P. Correlation of fasting serum C-peptide and insulin with markers of metabolic syndrome-X in a homogenous Chinese population with normal glucose tolerance. Int J Cardiol. 1999;68(2):179–86.

    Article  PubMed  CAS  Google Scholar 

  6. Bergstrom RW, Newell-Morris LL, Leonetti DL, et al. Association of elevated fasting C-peptide and increased intraabdominal fat distribution with development of NIDDM in Japanese American men. Diabetes. 1990;39(1):104–11.

    Article  PubMed  CAS  Google Scholar 

  7. Chailurkit LO, Jongjaroenprasert W, Chanprasertyothin S, Ongphiphadhanakul B. Insulin and C-peptide levels, pancreatic beta cell function, and insulin resistance across glucose tolerance status in Thais. J Clin Lab Anal. 2007;21(2):85–90.

    Article  PubMed  CAS  Google Scholar 

  8. Chen CH, Tsai ST, Chuang JH, Chang MS, Wang SP, Chou P. Population-based study of insulin, C-peptide, and blood pressure in Chinese with normal glucose tolerance. Am J Cardiol. 1995;76(8):585–8.

    Article  PubMed  CAS  Google Scholar 

  9. Efrat S. Prospects for treatment of type 2 diabetes by expansion of the beta-cell mass. Diabetes. 2001;50(Suppl 1):S189–90.

    Article  PubMed  CAS  Google Scholar 

  10. Porte D Jr. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. Diabetes/Metab Res Rev. 2001;17(3):181–8.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We thank members of the National Center for Health Statistics (NCHS) of the Centers for Disease Control (CDC) and Prevention and the participants who enrolled in the study. This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant Number, 2012R1A1A3017058).

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyoung-Bok Min.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Min, JY., Min, KB. Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals. Eur J Epidemiol 28, 771–774 (2013). https://doi.org/10.1007/s10654-013-9836-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-013-9836-5

Keywords

Navigation